BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.59 +0.02 (+1.27%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025)

BioNexus Gene Lab (BGLC) posted Work In Process of $190588.0 for Q3 2025, up 0.95% sequentially from $188797.0 in Q4 2024.

BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025) Analysis & Trends

BioNexus Gene Lab has reported Work In Process for 2 years, with the latest figure at $190588.0 in Q3 2025.

  • Quarterly Work In Process changed N/A year-over-year to $190588.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $190588.0 (changed N/A YoY) and the FY2024 annual result came in at $188797.0, changed N/A from the prior year.
  • Work In Process advanced to $190588.0 in Q3 2025 per BGLC's latest filing, from $188797.0 in the prior quarter.
  • Over five years, Work In Process peaked at $190588.0 in Q3 2025 and troughed at $188797.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 222.77 Bn 217.87 Bn 4.43 Bn
2 Sherwin Williams 84.55 Bn 84.26 Bn 3.34 Bn
3 Ecolab 78.89 Bn 73.75 Bn 1.95 Bn
4 Air Products & Chemicals 66.91 Bn 65.93 Bn 1.04 Bn
5 Ppg Industries 25.15 Bn 23.56 Bn 1.81 Bn
6 Chemical & Mining Co Of Chile 22.35 Bn 18.48 Bn 778.60 Mn
7 LyondellBasell Industries 22.02 Bn 19.39 Bn 2.04 Bn
8 International Flavors & Fragrances 21.27 Bn 20.70 Bn 853.00 Mn
9 DuPont de Nemours 18.86 Bn 17.12 Bn 639.00 Mn
10 BioNexus Gene Lab 2.26 Mn -1.26 Mn 12,982.00

Historic Data

Download Data
DateValue
Sep 30, 2025 190,588.00
Dec 31, 2024 188,797.00